Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-25-026184
Filing Date
2025-03-20
Accepted
2025-03-20 16:33:31
Documents
2
Period of Report
2025-03-11

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm259812-19_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm259812-19_3seq1.xml 3 1627
2 EXHIBIT 24 tm259812d19_ex24.htm EX-24 17257
  Complete submission text file 0001104659-25-026184.txt   20561
Mailing Address 1900 MARKET STREET SUITE 200 PHILADELPHIA PA 19103
Business Address 1900 MARKET STREET SUITE 200 PHILADELPHIA PA 19103 6177728515
abrdn Life Sciences Investors (Issuer) CIK: 0000884121 (see all company filings)

EIN.: 043147016 | State of Incorp.: MA | Fiscal Year End: 0930
SIC: 0000

Mailing Address C/O ABRDN 1900 MARKET STREET, SUITE 200 PHILADELPHIA PA 19103
Business Address
Gebauer Katie Lynn (Reporting) CIK: 0001968369 (see all company filings)

Type: 3 | Act: 34 | File No.: 811-06565 | Film No.: 25756970